References
- Rappuoli R. Reverse vaccinology. Curr.Opin. Microbia 3,445–450 (2000).
- Robinson HL. New hope for an AIDS vaccine. Nature Rev. Immunol. 2,239–250 (2002).
- Donnelly JJ, Ulmer JB, Shiver JW Liu MA. DNA vaccines. Ann. Rev. Immunol. 15,617–648 (1997).
- Berzofsky JA, Ahlers JD, Belyakov IM. Strategies for designing and optimizing new generation vaccines. Nature Rev. Immunol. 1, 209–219 (2001).
- Bertram EM, Dawicki W Watts TH. Role of T-cell costimulation in antiviral immunity. Semin. Immuna 16,185–196 (2004).
- Marciani DJ. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov. Today 8, 934–943 (2003).
- Romero P, Valmori D, Pittet MJ, et al. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CU in human melanoma. Immunol. Rev. 188,81–96 (2002).
- Appay V, Rowland-Jones SL. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin. Immunol. 16,205–212 (2004).